Supernus Pharmaceuticals reported $88.8M in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Abbott ABT:US $ 5691M 534M
Ani Pharmaceuticals ANIP:US $ 83.16M 1.46M
Aurora Cannabis Inc ACB:CN 129.9M 19.63M
Bristol Myers Squibb BMY:US $ 2104M 9M
Canopy Growth Corp WEED:CN C$ 204.39M 161.36M
Cara Therapeutics CARA:US 1.91M 677K
Corcept Therapeutics CORT:US $ 5.08M 0.09M
Eisai 4523:JP Y 99008M 6497M
Eli Lilly And LLY:US $ 3893M 7M
Endo International Ordinary Shares ENDP:US $ 283.83M 0.27M
JAZZ PHA JAZZ:US $ 985.45M 87.27M
Lannett LCI:US $ 95.43M 10.34M
Pacira Pharmaceuticals PCRX:US $ 103.66M 5.11M
Perrigo Ordinary Shares PRGO:US $ 1022.4M 2.2M
Pfizer PFE:US $ 9979M 920M
Revance Therapeutics RVNC:US $ 10.66M 0.5M
Supernus Pharmaceuticals SUPN:US $ 88.8M 2.84M
Teva Pharmaceutical Industries TEVA:US $ 4012M 194M
United Therapeutics UTHR:US $ 88.2M 5.6M
Xeris Pharmaceuticals Inc XERS:US $ 16.87M 1.25M